Introduction
COPD is a common condition that progresses into a life-threatening disease, and it has become the third leading cause of death in the world in 2012. 1 Population-based studies have demonstrated overall COPD prevalence rates of between 5% and 15%.
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The diagnosis of COPD is based on physiological pulmonary function tests using spirometry. Specifically, there must be persistent airflow obstruction (AO), defined by a post-bronchodilator forced expiratory volume in 1 second (FEV 1 )/forced vital capacity (FVC) ratio ,0.7, 12 or by agedependent values below the lower fifth percentile of this ratio (the lower limit of normal [LLN] ). 13, 14 However, it is difficult to screen the general population for COPD using spirometry, since it is not available in many settings. There is no proven benefit of using spirometry to screen adults who have no smoking history and no respiratory symptoms. 15 The use of simple COPD screening tools, such as the COPD Population Screener (COPD-PS) 16 and the International Primary Care Airways Guidelines (IPAG) questionnaires, 17 has been shown to be helpful for people at risk of developing COPD. These questionnaires reliably detect AO in the general population, and may facilitate the early, accurate diagnosis of COPD in general practice settings. 18, 19 However, the COPD-PS and IPAG questionnaires were originally developed and primarily validated in Western countries. We recently validated the COPD-PS and IPAG questionnaires in a general Japanese population and determined that the diagnostic cutoff point was different from the originally established cutoff points. 20, 21 One study found that the body mass index (BMI) item in the IPAG questionnaire was not statistically relevant in Japanese subjects who had early COPD identified by questionnaires. 22 Thus, these questionnaires may inadequately assess COPD in the general Japanese population. Therefore, for the early detection of COPD in general Japanese populations, we sought to develop an original persistent AO questionnaire as a COPD screening questionnaire (COPD-Q).
Methods Overview
To develop a self-scored persistent AO screening questionnaire, we performed the following two studies (Figure 1 ). In study I, a working group was assembled to generate initial draft items for the development of the COPD-Q. These items were administered to subjects at a comprehensive health examination 23 in Kagoshima Kouseiren Medical Health Care Center in Japan, and the final questionnaire items comprising the COPD-Q were determined statistically by comparing their responses to FEV 1 /FVC scores to identify individuals likely to have COPD.
In study II, the working group determined weighted scores for individual items and the cutoff point for the COPD-Q based on data derived from June 2015 to August 2015 from the Hisayama study, an ongoing, population-based epidemiologic study designed to investigate the morbidity, mortality, and risk factors of cardiovascular and smokingrelated diseases in the community of Hisayama, Japan.
Working group and item generation
The working group comprised three pulmonologists, one general physician, and one statistician, and met from August 2013 to April 2014 to generate initial draft items for the development of the COPD-Q. First, initial items were identified based on the following seven conceptual domains that were relevant to the detection of COPD and that could be easily evaluated by subjects: dyspnea, cough, phlegm, colds/bronchitis, wheezing, functional impact, and personal characteristics. The initial draft questionnaire consisted of 19 items (53 total questions) assessing the conceptual domains in terms of presence, frequency, duration, and/or quality.
study population
In study I, Japanese participants aged 40-79 years who received comprehensive health examinations at Kagoshima Kouseiren Medical Health Care Center were enrolled in this study.
Study II was based on data from the Hisayama study, a town located in a suburban area adjacent to Fukuoka City, a large urban center on Kyushu Island in the southern part of Japan. 
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The population of Hisayama is approximately 8,000 and has been stable for over 50 years. National census data show that the distributions of age and occupation in Hisayama have been almost identical to those across Japan since the 1960s.
study design
The initial draft questionnaire was administered to the participants of study I. Of the 2,367 subjects who were enrolled from April 2014 to February 2015, three were excluded due to having asthma and 26 were excluded because data were missing in their records. The final analysis included data for 2,338 subjects with fully completed initial draft questionnaires and valid spirometry measurements. A random subsample of subjects (22.9%) completed the survey again 2-4 weeks later to generate an estimate of test-retest reliability.
In study II, registered subjects aged 40 years and older were solicited to participate in a town-wide health checkup that included spirometry. Of the 2,598 subjects who were enrolled from June 2015 to August 2015, 532 were excluded for the following reasons: 342 were not between the ages of 40 and 79 years, 67 had physician-diagnosed asthma, 12 had a previous lung resection, two had poor study data, and 64 had records with missing data. Furthermore, 45 subjects who had pre-bronchodilator FEV 1 /FVC ,0.70 were not eligible for post-bronchodilator testing because of underlying heart disease or other reasons. The final analysis included data for 2,066 subjects who had fully completed the COPD-Q and had valid spirometry measurements.
All subjects underwent spirometry using a CHEST-GRAPH HI-105 spirometer (Chest MI, Tokyo, Japan). The subjects performed at least three FVC maneuvers according to the recommended methods. The data were examined by two pulmonary physicians who visually inspected the flow-volume curves and excluded subjects with poor study data. The highest FEV 1 and FVC values were used in the present study. The reference values for percent predicted FEV 1 were based on Japanese criteria. Subjects with a prebronchodilator FEV 1 /FVC ,0.70 were required to undergo post-bronchodilator spirometry after 15-minute inhalation of salbutamol (GlaxoSmithKline, Tokyo, Japan) via a metered-dose inhaler with a spacer, according to the recommended procedure. Persistent AO was defined as a postbronchodilator FEV 1 /FVC ,0.70. The severity of subjects with persistent AO was categorized in accordance with the Global Initiative for Chronic Obstructive Lung Disease criteria (mild, FEV 1 $80% predicted; moderate, FEV 1 50%-80% predicted; severe, FEV 1 30%-50% predicted; very severe, FEV 1 ,30% predicted). 
statistical analysis
The demographic characteristics of each study population and the questionnaire results were summarized with descriptive statistics. For subjects who used a bronchodilator, the post-bronchodilator FEV 1 /FVC values were utilized as the FEV 1 /FVC data. Each demographic characteristic was compared between groups using the Kruskal-Wallis test.
For study I, univariate/multivariate logistic regression models were used to compare questionnaire responses in the No-AO and AO groups, and to investigate initial draft items for the development of the COPD-Q. Test-retest reliability of the initial draft questionnaire was assessed with Pearson's correlations between scores at study entry and after 2-4 weeks of follow-up.
For study II, multivariate logistic regression analysis was performed to determine the weighted scores of each response to questions in the COPD-Q and to identify the COPD-Q cutoff point that would discriminate between subjects with and without persistent AO.
Sensitivity, specificity, and positive (PPV) and negative predictive value (NPV) were calculated. Receiver operating characteristic (ROC) curves were generated and area under the ROC curves (AUC) were determined to reflect the ability of the COPD-Q to discriminate between subjects with and without persistent AO graphically and quantitatively. Distribution of the number of subjects and COPD-Q scores, and their estimated probabilities of AO were evaluated.
These statistical analyses were performed using STATA Release 13 (StataCorp, College Station, TX, USA) and SAS Release 9.4 (SAS Institute Inc., Cary, NC, USA). Results were considered statistically significant when P,0.05. Table 1 shows the baseline characteristics of the 2,338 subjects in study I, stratified by AO category following post-bronchodilator spirometry. The majority of subjects (95.8%) showed an initial FEV 1 /FVC $0.70. Following postbronchodilator spirometry, 2.8% were found to have AO. Many AO subjects (89.2%) were estimated as having mild or moderate COPD, while only 10.8% of AO subjects had severe or very severe COPD. AO subjects were older, predominantly male, had a higher number of pack-years smoked, and were more likely to be former or current smokers (Table 1) .
Results
study 1: subject characteristics
Questionnaire item selection
The 19 initial draft items were administered to all 2,338 subjects. Less than 4.0% of total item-level data were missing. Scale reliability was confirmed with the test-retest reliability method, with analysis of 535 subjects (22.9%) who completed the study survey at entry and at 2-4 weeks of follow-up. In this population, the test-retest Pearson's correlation coefficient was 0.946 (P,0.001).
Initial univariate logistic regression analysis was performed on the initial draft items (Tables S1 and 2 ). As stated above, items were grouped into the following conceptual domains: dyspnea, cough, phlegm, wheezing, functional impact, and personal characteristics. A combination of one item based on two conceptual domains, namely cough and phlegm, and one based on dyspnea on exertion, showed a significant ability to discriminate between subjects with and without AO. The final version of the COPD-Q consisted of the five questions (Q) that demonstrated the greatest discriminatory capacity: How old are you? (Q1); How often do you cough up phlegm when you are not sick? (Q2); Are you prone to being out of breath when running or carrying a heavy load, compared to people of your own age group? (Q3); In the past year, have you ever had wheezing or whistling when breathing while running or carrying a heavy load? (Q4); How many cigarettes do you smoke? (Brinkman index: the number of cigarettes × the number of years) (Q5). Table 2 presents the results of univariate logistic regression analysis of these five questions (COPD-Q) as a screening questionnaire for persistent AO estimated to have COPD. Table 3 presents the results of odds ratios, and the corresponding 95% confidence intervals [CIs] were obtained by multivariable logistic regression analysis using age and cigarette consumption as covariates.
study II: subject characteristics Table 4 shows the baseline characteristics of the 2,069 subjects, based on data from the Hisayama study, stratified 
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Development of a COPD screening questionnaire by airflow limitation category following post-bronchodilator spirometry. The majority of subjects (95.2%) showed an initial FEV 1 /FVC $0.70. Following post-bronchodilator spirometry, 4.8% were found to have AO. Almost all AO subjects (93.0%) were classified as having mild or moderate COPD, while only 7.0% had severe or very severe COPD. As in study I, AO subjects were older, predominantly male, had a higher number of pack-years smoked, and were more likely to be former or current smokers (Table 4) .
Item-weighted scoring and cutoff point
The COPD-Q was administered to all 2,069 subjects in Hisayama, and several versions of weighted scores were assessed to produce the best results for discriminating between patients with and without AO. We ultimately derived weighted scores for the five COPD-Q questions according to individual coefficients of the multivariate logistic regression analysis (Table 5 ). Responses to each question were assigned weighted scores (specifically, depending on the question, 0 or 1; 0, 1, or 2; or 0, 1, 2, or 3) based on the relative contribution of the response to identifying AO, and response values were summed across the items to produce a scale score ranging from 0 to 10. Three of the five COPD-Q assessed COPD-related symptoms, namely coughing up phlegm (Q2; 5-point scale), breathlessness on exertion (Q3; 2-point scale), and wheezing on exertion (Q4; 5-point scale). One evaluated subject age (Q1; four categories), and the last assessed smoking history (Q5; 4-point scale) (Figures 2 and S1 ). An ROC curve was generated to evaluate the ability of the final version of the COPD-Q to discriminate subjects without AO from those with AO in study II (Hisayama study) (Figure 3 ). The overall AUC for the continuous COPD-Q score for discriminating AO from No AO was 0.796 (95% CI, 0.750-0.841). The appropriateness of various cutoff points of the COPD-Q was then evaluated (Table 6) . A cutoff of 4 points showed a sensitivity of 71.0% and a specificity of 70.1%. The PPV was 10.8%, 
Discussion
The five-item, self-scored COPD-Q is a simple and reliable Japanese-language questionnaire that was developed to screen for persistent AO estimated to have COPD in a general Japanese population. In study I, the working group generated initial draft items derived from 19 items comprising 53 total questions based on seven conceptual domains. Ten items demonstrated a particularly strong relationship to COPD. Although BMI was assessed by an item in the IPAG questionnaire, it was not a significant predictive factor for AO in this study (Tables 1  and 4 ), a result that is consistent with a previous report. 22 An obvious problem concerning BMI is that the cutoff values of BMI of 25.4 and 29.7 kg/m 2 in the IPAG questionnaire are well above the average BMI of Japanese subjects, and even above the Japanese criteria for obesity of 25.0 kg/m 2 . Thus, there are reports stating that modified cutoff values for BMI should be used for determining the discriminatory power of the IPAG questionnaire for the Japanese population. 22, 24 However, regarding BMI in the present study, there were no significant differences between subjects with AO and those without AO in study I (Table 1) or study II (Table 4) , and as a result, we excluded BMI as an item in the COPD-Q. In addition, some reports have shown that the association between BMI and 
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samukawa et al mortality was especially significant in severe COPD and differed according to the severity of AO; 25, 26 however, subjects of AO in the present study (89.2% in study I and 93.0% in study II) were in Global Initiative for Chronic Obstructive Lung Disease stage I and II. The BMI in subjects with early-detected COPD may not be a significant item in Japanese population.
Univariate logistic regression analyses were used to identify five items that predicted COPD (Table 2) . Coughing, as identified by a general clinician in relation to COPD, did not by itself distinguish between subjects with AO and those without AO. The combination of coughing and phlegm production (addressed by Q2) showed significant discriminatory ability, similar to that of dyspnea on exertion (addressed by Q3), and the ORs of both Q2 and Q3 were significant in a multivariate logistic regression analysis (Table 3) .
Study I has several limitations regarding data interpretation. The prevalence of persistent AO estimated to have COPD was 2.8%, which is very low compared with a previous report. 7 The study population comprised individuals who voluntarily agreed to participate in an annual comprehensive health examination program that is conducted in Japan to detect potential health risks at an early stage. 23 This survey population may be healthier or more health conscious than the general Japanese population, which would affect the prevalence of persistent AO estimated to have COPD in study I. Therefore, we analyzed the weighted scores for individual items and established a cutoff point for the COPD-Q based on the data from the Hisayama study (study II). It is necessary in the future to confirm the performance of the COPD-Q in other validation cohorts.
In study II, the five items on the COPD-Q were scored as 0, 1, 2, or 3 based on coefficients of multivariate logistic regression analysis for identifying AO, with a summed total score ranging from 0 to 10 ( Figure 2) . To evaluate the contribution of smoking status, we used the Brinkman index and derived weighted scores based on coefficients of multivariate logistic regression analysis for predicting COPD. The COPD-PS 16 used the question "Have you smoked at least 100 cigarettes in your ENTIRE LIFE", and a "Yes" response was assigned a value of 2. Conversely, in the present study, the responses to the smoking status item were assigned values of 0, 1, 2, or 3, because a total Brinkman index value over 1,000 was most useful for distinguishing COPD (Table 5) .
The overall AUC for the continuous COPD-Q score was 0.796 (95% CI, 0.750-0.841) (Figure 3) . In a previous study, we administered the COPD-PS and IPAG questionnaires to a general Japanese population (Hisayama study), 21 and found that the overall AUC for the COPD-PS was 0.747 (95% CI, 0.707-0.788) and 0.775 (95% CI, 0.735-0.816) for the IPAG questionnaire. In the present study with almost the same population, the COPD-Q showed a large AUC for distinguishing subjects with AO from those without AO compared to the COPD-PS and IPAG questionnaire.
The PPV of 10.8% with a COPD-Q cutoff point of 4 is lower than the PPVs obtained using the COPD-PS and IPAG questionnaires in our previous study. 21 However, PPV and NPV vary with disease prevalence, with PPV decreasing with lower disease prevalence. The NICE study estimated that the COPD prevalence in Japan ranged from 8.6% to 10.9%. 7 In residents aged 40 years or older from Hisayama, Matsumoto et al estimated that the combined prevalence of COPD and a COPD phenotype with variable airflow limitation was 9.3%. Abbreviations: COPD-Q, COPD screening questionnaire; Or, odds ratio; aUC, area under the receiver operating characteristic curve.
Figure 4
The relationship between COPD-Q score and estimated probability of aO (%). Bars represent the number of aO subjects. Black circles: observed aO (%), curve: estimated aO (%), dotted curves: 95% CI, and horizontal axis: COPD-Q scores. Abbreviations: COPD-Q, COPD screening questionnaire; AO, airflow obstruction; CI, confidence interval.
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Development of a COPD screening questionnaire However, the prevalence of confirmed persistent AO in the present study was 4.8% (Table 3) in residents from Hisayama aged 40-79 years. The following reasons may account for the underestimated persistent AO prevalence in study II. First, 342 subjects were excluded from the present study because they were not between 40 and 79 years old, and since the prevalence of COPD increases with older age, this age restriction may have affected the prevalence of AO. The prevalence of AO was previously found to be 19% in individuals in Hisayama between the ages of 80 and 89 years. 27 The second potential reason for the underestimated persistent AO prevalence is that 67 subjects with physician-diagnosed asthma were excluded; however, these subjects may have had a COPD phenotype with variable AO, which exhibits features of both asthma and COPD. [28] [29] [30] The third possible explanation is that the 45 subjects with pre-bronchodilator FEV 1 /FVC ,0.7 were ineligible for post-bronchodilator testing and were excluded from the present study, and this group may have included subjects with persistent AO.
Another limitation of this study was that persistent AO estimated to have COPD was defined as a post-bronchodilator FEV 1 /FVC ,0.7 without using an LLN, though previous studies demonstrated the successful use of an LLN for defining AO in Japanese populations. 31, 32 Application of an LLN value for determining the existence of COPD may prevent overdiagnosis in elderly subjects and underdiagnosis in young subjects. 33 Despite these limitations, the COPD-Q developed in the present study was found to be a simple and useful screening questionnaire for persistent AO in a general Japanese population.
Conclusion
The COPD-Q is a five-item screening questionnaire for persistent AO. Although validation studies are necessary to confirm the performance of the COPD-Q in other cohorts, the COD-Q can be evaluated for its utility as a first-stage screening tool for detecting COPD in the general Japanese population.
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Development of a COPD screening questionnaire P-value for trend =0.110 Q19 how much of the time have you lived in an environment where you were breathing exhaust gas or polluted air? always na sometimes 1.7 0.9-3.2 almost never 1.0 reference Notes: na: not available because of no subjects in both/either cases and controls. *Odds ratios and corresponding 95% Cls were estimated models by logistic regression using age and cigarette consumption as covariates. **Odds ratios were estimated using "no" group as reference for all conditions. ***"almost none" group was used as reference, and the risk estimates for the remaining groups are shown for all conditions. Abbreviations: CI, confidence interval; NA, not available.
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